TY - JOUR
T1 - Infective Endocarditis Is a Risk Factor for Heparin Resistance in Adult Cardiovascular Surgical Procedures
T2 - A Retrospective Study
AU - Kimura, Yoshikazu
AU - Okahara, Shuji
AU - Abo, Kanae
AU - Koyama, Yusuke
AU - Kuriyama, Mitsuhito
AU - Ono, Kazumi
AU - Hidaka, Hidekuni
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/12
Y1 - 2021/12
N2 - Objectives: Heparin resistance (HR), defined as a decrease in heparin responsiveness, can result in adverse events with prolonged duration of surgery. Although some clinical risk factors have been suggested, the relationship with the surgical diagnosis is unclear. The aim of present study was to elucidate the clinical predictors of HR including the surgical diagnosis. Design: This retrospective cohort study determined the incidence of HR (defined as activated clotting time [ACT] <400 seconds after 250-350 IU/kg of heparin administration) and heparin sensitivity index (HSI) was calculated from the rate of change in ACT per heparin dose. Preoperative demographic data, medication history, and laboratory data also were analyzed. Setting: Single institution, tertiary care hospital. Participants: Adult patients who underwent cardiovascular surgery with cardiopulmonary bypass between January 2012 and September 2018. Interventions: None. Measurements and Main Results: Of 287 patients, 88 (30.7%) were classified as HR. In univariate analysis, infective endocarditis (IE), platelet count, and serum fibrinogen and albumin levels were associated with HR. After adjustment for baseline ACT and initial heparin dose, IE (odds ratio 4.57, [95% CI: 1.10-19.1]; p = 0.037) and albumin ≤3.5 g/dL (3.17, [1.46-6.93]; p = 0.004) were associated independently with HR. Patients with IE had significantly lower HSI than those with other diseases. All HR patients were treated with additional heparin, and 17 of them received human antithrombin-III concentrate. Conclusions: Infective endocarditis and preoperative hypoalbuminemia were associated independently with HR. The optimal anticoagulation strategy for patients with these risk factors requires further investigations based on the authors’ findings.
AB - Objectives: Heparin resistance (HR), defined as a decrease in heparin responsiveness, can result in adverse events with prolonged duration of surgery. Although some clinical risk factors have been suggested, the relationship with the surgical diagnosis is unclear. The aim of present study was to elucidate the clinical predictors of HR including the surgical diagnosis. Design: This retrospective cohort study determined the incidence of HR (defined as activated clotting time [ACT] <400 seconds after 250-350 IU/kg of heparin administration) and heparin sensitivity index (HSI) was calculated from the rate of change in ACT per heparin dose. Preoperative demographic data, medication history, and laboratory data also were analyzed. Setting: Single institution, tertiary care hospital. Participants: Adult patients who underwent cardiovascular surgery with cardiopulmonary bypass between January 2012 and September 2018. Interventions: None. Measurements and Main Results: Of 287 patients, 88 (30.7%) were classified as HR. In univariate analysis, infective endocarditis (IE), platelet count, and serum fibrinogen and albumin levels were associated with HR. After adjustment for baseline ACT and initial heparin dose, IE (odds ratio 4.57, [95% CI: 1.10-19.1]; p = 0.037) and albumin ≤3.5 g/dL (3.17, [1.46-6.93]; p = 0.004) were associated independently with HR. Patients with IE had significantly lower HSI than those with other diseases. All HR patients were treated with additional heparin, and 17 of them received human antithrombin-III concentrate. Conclusions: Infective endocarditis and preoperative hypoalbuminemia were associated independently with HR. The optimal anticoagulation strategy for patients with these risk factors requires further investigations based on the authors’ findings.
KW - anticoagulation
KW - cardiopulmonary bypass
KW - heparin resistance
KW - hypoalbuminemia
KW - infective endocarditis
UR - http://www.scopus.com/inward/record.url?scp=85108119660&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108119660&partnerID=8YFLogxK
U2 - 10.1053/j.jvca.2021.05.024
DO - 10.1053/j.jvca.2021.05.024
M3 - Article
C2 - 34144872
AN - SCOPUS:85108119660
SN - 1053-0770
VL - 35
SP - 3568
EP - 3573
JO - Journal of Cardiothoracic and Vascular Anesthesia
JF - Journal of Cardiothoracic and Vascular Anesthesia
IS - 12
ER -